Skip to main content
. 2023 Jul 13;14(5):2016–2028. doi: 10.1002/jcsm.13280

Table 2.

Baseline data for propensity‐score‐matched groups by gender

Gender
Male Female
All CKD Controls P‐values All CKD Controls P‐values
n 66 33 33 34 17 17
Anthropometric data
Age (years), median (IQR) 71 (10) 71 (10) 70 (9) 0.096 67 (6) 67 (5) 66 (7) 0.468
BMI (kg/m2), median (IQR) 27.8 (4.6) 27.4 (4.2) 28.0 (4.6) 0.994 27.2 (7.1) 28.9 (9.6) 25.6 (7.2) 0.274
Charlson, median (IQR) 5 (3) 7 (2) 4 (2) <0.001 4 (3) 6 (2) 3 (2) <0.001
SGA, n (%) 0.999
A 100% 100% 100% 33 (97.1%) 16 (94.1%) 17 (100%)
B 0 0 0 1 (2.9%) 1 (5.9%) 0
Diabetes, n (%) 31 (47.0%) 13 (39.4%) 18 (54.6%) 0.218 13 (38.2%) 6 (35.3%) 7 (41.2%) 0.724
Blood pressure (mmHg), median (IQR)
Systole 140 (20) 140 (20) 130 (22) 0.052 140 (25) 145 (16) 130 (23) 0.306
Diastole 76 (11) 78 (10) 70 (15) 0.072 70 (10) 70 (8) 70 (11) 0.999
Heart rate (b.p.m.), median (IQR) 70 (15) 69 (14) 72 (15) 0.131 70 (12) 70 (14) 70 (11) 0.865
Dominant arm (% right‐handed) 98.5% 97.0% 100% 0.999 97.1% 94.1% 100% 0.999
MVF (N), median (IQR) 293.5 (92.8) 270.0 (77.7) 307.2 (83.4) 0.024 199.5 (60.3) 174.5 (48.5) 212.1 (37.3) 0.002
Biochemical data
Haemoglobin (mg/dL), median (IQR) 13.8 (3.1) 12.4 (2.0) 15.1 (1.4) <0.001 12.7 (2.0) 11.7 (1.3) 13.5 (0.9) 0.027
Sodium (mmol/L), median (IQR) 140 (3) 141 (2) 140 (4) 0.564 141 (5) 141 (6) 141 (4) 0.656
Potassium (mmol/L), median (IQR) 4.5 (0.7) 4.5 (0.6) 4.3 (0.7) 0.485 4.4 (0.5) 4.3 (0.4) 4.6 (0.5) 0.142
Creatinine (μmol/L), median (IQR) 114 (151) 233 (140) 77 (14) <0.001 89 (84) 153 (80) 62 (14) <0.001
eGFR CKD‐EPI (mL/min/1.73 m2), median (IQR) 55 (63) 24 (15) 88 (12) <0.001 55 (53) 34 (21) 88 (9.5) <0.001

Bold P‐values are considered statistically significant.

Abbreviations: BMI, body mass index; CKD, chronic kidney disease; eGFR CKD‐EPI, estimated glomerular filtration rate with the Chronic Kidney Disease Epidemiology Collaboration equation; IQR, interquartile range; MVF, maximum voluntary force; N, Newton; SGA, subjective global assessment.